Literature DB >> 2433596

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.

I W Caras, M A Davitz, L Rhee, G Weddell, D W Martin, V Nussenzweig.   

Abstract

Decay-accelerating factor (DAF), a glycoprotein that is anchored to the cell membrane by phosphatidylinositol, binds activated complement fragments C3b and C4b, thereby inhibiting amplification of the complement cascade on host cell membranes. Here, we report the molecular cloning of human DAF from HeLa cells. Analysis of DAF complementary DNAs revealed two classes of DAF messenger RNA, one apparently derived from the other by a splicing event that causes a coding frameshift near the C terminus. The apparent 'intron' sequence contains an Alu family member and encodes contiguous protein sequence. Two DAF proteins are therefore possible, having divergent C-terminal domains which differ in their hydrophobicity. Both mRNAs are found on polysomes, suggesting that both are translated. We propose that the major (90%) spliced DAF mRNA encodes membrane-bound DAF whereas the minor (10%) unspliced DAF mRNA may encode secreted DAF and we present expression data supporting this. The deduced DAF sequence contains four repeating units homologous to a consensus repeat found in a recently described family of complement proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433596     DOI: 10.1038/325545a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  97 in total

1.  Alu-containing exons are alternatively spliced.

Authors:  Rotem Sorek; Gil Ast; Dan Graur
Journal:  Genome Res       Date:  2002-07       Impact factor: 9.043

2.  Prototypic sequences for human repetitive DNA.

Authors:  J Jurka; J Walichiewicz; A Milosavljevic
Journal:  J Mol Evol       Date:  1992-10       Impact factor: 2.395

3.  New member of the multigene family of complement control proteins in herpesvirus saimiri.

Authors:  J C Albrecht; B Fleckenstein
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.

Authors:  B J Scallon; E Scigliano; V H Freedman; M C Miedel; Y C Pan; J C Unkeless; J P Kochan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  The majority of human genes have regions repeated in other human genes.

Authors:  Roy J Britten
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-31       Impact factor: 11.205

7.  Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.

Authors:  D M Lublin; E S Thompson; A M Green; C Levene; M J Telen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

8.  Intercellular transfer of a glycosylphosphatidylinositol (GPI)-linked protein: release and uptake of CD4-GPI from recombinant adeno-associated virus-transduced HeLa cells.

Authors:  S M Anderson; G Yu; M Giattina; J L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

9.  Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement.

Authors:  F Pardo-Manuel; J Rey-Campos; A Hillarp; B Dahlbäck; S Rodriguez de Cordoba
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

10.  A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.

Authors:  D V Tambourgi; T L Kipnis; W D da Silva; K A Joiner; A Sher; S Heath; B F Hall; G B Ogden
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.